Sustained infusions of norepinephrine (NE) are known to produce deleterious pathophysiologic effects on the circulatory system. The mechanisms responsible for these effects were investigated in 25 dogs; 17 were treated with selective block of alpha receptors by phenoxybenzamine or of beta receptors by propranolol, or by both agents, and then infused with NE (4 /ig-kg-1 -min-1 ) for 4 hours; 8 control animals were given only adrenergic blocking agents. Left ventricular and systemic pressure, cardiac output and arterial blood gases were measured at selected intervals throughout the infusion period, and histologic examinations of the heart and other vital organs were performed at the conclusion of each study. In animals with alpha-receptor blockade, NE infusions were associated with extensive subendocardial hemorrhage and focal myofiber fatty degeneration, yet blood pressure, cardiac output, and derived cardiac work parameters were well maintained. In animals with beta-receptor blockade, NE caused minimal pathologic changes in the heart despite significant reduction in cardiac output, minute and stroke work, and significant increase in left ventricular end-diastolic pressure (LVEDP) and peripheral vascular resistance. In animals receiving combined alpha-and beta-receptor blockade, NE infusions were not associated with significant hemodynamic or morphologic abnormality. These findings indicate: (1) the hemodynamic abnormalities are the result of the action of NE mediated primarily through alpha receptors; (2) the morphologic changes are produced by NE mediated mostly through beta receptors; and (3) the reductions in cardiac output and minute and stroke work and the increase in LVEDP produced by sustained NE infusions are not necessarily a consequence of the pathologic changes which develop in the heart muscle.
• Sustained infusions of 1-norepinephrine (NE) in patients and experimental animals have been associated with a wide variety of cardiovascular lesions (1) (2) (3) . Previous studies from this laboratory documented a progressive deterioration in cardiac function with 4-hour systemic infusions of NE (4) . These circula-administration. The present report describes the results of these studies.
Methods
Twenty-five mongrel dogs weighing 10 to 34 kg were anesthetized with intravenous sodium pentobarbital, 25 mg/kg, and mechanically ventilated with room air through a cuffed endotracheal tube. Norepinephrine base was diluted in 40 ml of dextrose and water and infused into a femoral vein of the experimental animals for 4 hours at a dose of 4 fig • kg-1 • min. The control animals were infused intravenously with 40 ml of 5% dextrose and water over a 4-hour period. This dose of NE was selected on the basis of previous experiments which demonstrated a moderate hypertensive effect and uniform pathologic changes (4, 5) . Measurements of left ventricular and femoral artery pressure, cardiac output and arterial blood pH and oxygen saturation (4) were made before NE infusion, at 15 minutes and 1, 2, 3 and 4 hours during the infusions. The peripheral vascular resistance (PVR), left ventricular minute work (MW) and stroke work (SW) were calculated from the pressure and flow data. Autopsy examinations with particular attention to the cardiovascular system were performed on all animals within 15 minutes after the end of the infusion. A minimum of two blocks of tissue from each of the atria and ventricles and from the interventricular septum were used to prepare no less than 20 paraffin and frozen sections from each area. The paraffin sections were stained with hematoxylin and eosin and with acid fuchsin (7) . Frozen sections cut on a cryostat were stained with oil red 0 for lipid, and by the tetrazolium method for lactic and succinic dehydrogenase (8) .
Five groups of alpha-and beta-receptor blocking experiments were carried out (groups I-V). The hemodynamic and pathologic data from the previously reported studies in which NE was infused at the same rate (4, 5,) are included as group VI so that the reader can more easily make comparisons between the effects of NE with and without adrenergic blockade (Table 1) . Control hemodynamic measurements were made before adrenergic blockade, and baseline values were obtained after blockade but before beginning the 4-hour NE infusions. Phenoxybenzamine was administered in a single intravenous dose, 1 mg/kg, before either NE or dextrose infusion. Propranolol was given intravenously at an initial dose of 0.25 mg/kg, and at subsequent doses of 0.125 mg/kg, at hourly intervals throughout the 4-hour infusions.
These doses of the adrenergic blocking agents were selected on the basis of a few preliminary experiments. Phenoxybenzamine, 1 mg/kg, iv, prevented any increase in peripheral vascular resistance to challenging infusions of 4 yLt g • kg" 1 • min-1 NE. An initial dose of propranolol, 0.25 mg/kg, was selected because it produced an effective chronotropic block to sustained NE infusions. When similar hourly follow-up doses of propranolol were administered, the animals survived less than 2 hours during the NE infusion. For this reason, the hourly propranolol doses were reduced in half, i.e., to 0.125 mg/kg. Even then, three of seven group II dogs died between the third and fourth hour of NE administration.
Results

HEMODYNAMIC DATA (TABLES 1 AND 2)
During NE infusion alone (group VI), a progressive and significant increase in left ventricular end-diastolic pressure (LVEDP), heart rate and peripheral vascular resistance ensued and the cardiac output and minute and stroke work were significantly reduced without appreciable change in systemic pressure (4) . When the alpha receptors were blocked (group I), the only significant hemodynamic change after 4 hours of NE infusion was an increase in heart rate. When beta receptors were blocked by previous treatment with propranolol (group II), infusions of NE produced significant increases in systemic pressure, LVEDP, and peripheral vascular resistance, and decreases in cardiac output, minute and stroke work, and heart rate. When NE was administered to animals in which both alpha and beta receptors were blocked, cardiac output and heart rate were diminished and peripheral vascular resistance was increased. No significant hemodynamic changes were observed in the control dogs whose alpha receptors were blocked (group IV), but significant depression of cardiac function was evident in the control dogs whose beta receptors were blocked (group V).
The time course of the inter-relationship between left ventricular stroke work (LVSW) and LVEDP in all six groups is presented in Figure 1 . In group II (beta-receptor block+ NE) and group VI (NE), LVSW diminished and LVEDP increased progressively during the last 3 hours of the NE infusion. Beta-receptor blockade alone (group Left ventricular stroke work (LVSW) in gram-meters/beat plotted against left ventricular end-diastolic pressure (LVED) in mm Hg for the six experimental groups. See text for drug dosage and details. The data for NE alone (group VI) are taken from a previous publication from this laboratory (4) . C: control value; B: value after adrenergic blockade but before NE infusion; 15'; 15 minutes of NE infusion; 1, 2, 3, and 4: the duration in hours of NE infusion. In group III, three of seven animab died between the third and fourth hour of NE infusion. V) was associated with a progressive increase in LVEDP but without reduction in LVSW. In contrast, LVSW and LVEDP showed Norepinephrine infusion in dogs whose alpha receptors were blocked (group I) produced a left ventricular systolic pressure which significantly exceeded systemic artery systolic pressure during the first 2 hours ( Table 2 ). Pressure tracings taken during withdrawal of the catheter from the left ventricle to the aorta showed that the pressure difference was located across the aortic outflow tract in the subvalvular region. During the 4-hour NE infusion, arterial oxygen saturation remained above 86% in all five groups. Arterial blood pH decreased progressively in groups I and II to pH 7.23, but did not change significantly in group III, IV and V (Table 3) .
MORPHOLOGIC CHANGES (TABLE 4)
Group 7.-All of the hearts showed extensive subendocardial hemorrhage which was most prominent in the left ventricle and often involved the entire left ventricular endocardium (Fig. 2) . Right ventricular subendocardial hemorrhage, although present in all cases, was always of a lesser degree than that seen on the left side. The subendocardial hemorrhagic process usually extended into the left ventricular wall and the septum to a depth of 1 to 2 mm, but occasionally extended through the entire wall. Subendocardial hemorrhages in the right ventricle rarely extended to a depth greater than 1 mm. All of the hearts in this group showed slight to moderate left ventricular dilatation and slight right ventricular dilatation.
Microscopic section showed, in addition to subendocardial and intramyocardial hemorrhages, extensive but patchy areas of myofiber degeneration. These areas of myolysis showed zonal fragmentation of myofibers, increased fuchsinophilia, lipid droplet accumulation (Fig. 3) , and both a patchy loss of succinic dehydrogenase (SDH) and lactic dehydrogenase (LDH) activity (Fig. 4) . All other organs, including the adrenals, showed no structural changes.
Group II.-AH of the hearts were flabby and left and right ventricular dilatation was either moderate or marked. Subendocardial hemorrhage was variable both as to the extent and depth of involvement of the ventricular Alpha-receptor blockade followed by NE infusion (group I). Extensive subendocardial and intramyocardial hemorrhages are present in both the left and right ventricles, and there is slight ventricular dilatation.
FIGURE 3
Alpha-receptor blockade followed by NE infusion (group I), There is focal myofiber fatty degeneration. Oil red 0 stain X 100. Alpha-receptor blockade followed by NE infusion (group 1). Croups of myofibers show both a loss of lactic dehydrogenase and clumping of the enzyme in the form of coarse granules adjacent to the intercalated discs. Tetrazolium method for lactic dehydrogenase X 100.
FIGURE 5
Beta-receptor blockade followed by NE infusion (group II). Prominent biventricular dilatation is present and only slight focal subendocardial hemorrhage is evident. All values are means + SE, in mm Hg. *LV = left ventricular systolic pressure (mm Hg); fSystem. = systemic arterial systolic pressure (mm Hg); Significantly reduced below LVS when analyzed by "paired sample analysis ( P < .05). wall. In four cases this was of a moderate degree, in the other three it was slight. In all cases in this group (Fig. 5) , the degree of subendocardial hemorrhage was less than that seen in group I animals.
Microscopic sections showed subendocardial hemorrhage with slight focal intramural extension in five animals. Myofiber degeneration and necrosis of a slight focal nature were seen within areas of hemorrhage in three animals. Lipid droplet accumulation, a change in mitochondrial size and staining, and loss of respiratory enzyme activity were present focally and to a slight degree in these three animals.
Adrenalitis characterized by extensive polymorphonuclear cell infiltration in the adrenal cortex was present in all cases in this group. No abnormal structural changes were seen in any other organs.
Group III.-The hearts from three animals in this group showed very slight focal subendocardial hemorrhages in the left ventricle. None of the hearts appeared to be dilated and there were no structural abnormalities of the myofibers on microscopic examination. No evidence of adrenalitis was found.
Groups IV and V.-The hearts from three animals in each of these groups showed very slight focal subendocardial hemorrhages in the left ventricle. None of the hearts appeared to be dilated and there were no structural abnormalities of the myofibers on microscopic examination. The adrenals were normal.
Group VI.-Detailed pathologic examination has been presented in a previous report (5) . In summary, cardiac dilatation, subendocardial hemorrhage, myofiber degeneration and adrenalitis were present to a marked degree.
Discussion
In previous investigations from this laboratory, the progressive decline in cardiac performance during sustained NE infusions was ascribed in large part to the myocardial lesions produced by NE (4-6). These assumptions could not be substantiated in the present set of experiments in which we administered selective adrenergic blocking agents before NE infusion. The myocardial lesions of subendocardial hemorrhage (myofiber necrosis and fatty myocellular degeneration) occurred primarily during activation of beta receptors by NE (group I: alpha-receptor block + NE) when circulatory pressure and flow were well maintained. Hemodynamic abnormalities of decreased cardiac output and minute and stroke work, and increased LVEDP and peripheral vascular resistance developed during activation of alpha receptors by NE (group II: beta-receptor block + NE) when only slight myofiber necrosis was evident on histologic examination. These circulatory disturbances in group II animals were qualitatively similar to those observed during unblocked NE infusions (group VI) (4). These findings indicate that the circulatory disturbances produced by NE are not necessarily a consequence of the histologic changes in the heart muscle.
The protection of the myocardium from extensive NE-induced pathologic changes by propranolol is in agreement with the recent report of Hoak et al. (9) . In contrast, Nash observed that the myocardial hemorrhage produced by epinephrine was unaffected or increased by propranolol (10) . The discrepancy between Nash's results and ours may relate to the different agents used in the two studies, the total dose of agonist and antagonist given, or the frequency of propranolol administration. Nash administered epinephrine, 10 fig • kg" 1 • mirj-1 , for 2 hours, and only one dose of propranolol, 2 mg/kg, iv, at the onset of epinephrine infusion. In the present study, we administered 4 fig • kg" 1 • min" 1 of NE for 4 hours; an initial dose of propranolol was given before the onset of NE infusion and was followed by additional propranolol doses at hourly intervals to a total dose of 0.625 mg/kg. Although a number of investigators have observed some protection against catecholamine-induced myocardial lesions with a variety of alpha-receptor blocking agents (3, (11) (12) (13) (14) (15) , the discrepancy in experimental design between those studies and the present investigation makes any comparison difficult.
The adrenalitis that develops during sustained NE infusions in the dog (5) is related to the alpha adrenergic effects of NE that may cause a local ischemia due to excessive constriction of the adrenal vasculature. However, the extent of polymorphonuclear cell infiltration of the adrenal cortex seems out of proportion to the minor degree of cortical cell nuclear pycnosis and cytoplasmic eosinophilia. As yet, we have no adequate explanation for this acute NE-induced change.
Complete beta-receptor blockade was not obtained in this study. The increase in cardiac output during the first hour of NE administration to the animals with beta-receptor blockade (group II) suggests incomplete inotropic blockade. On the other hand, stability of the heart rate below control values throughout the 4-hour NE infusion in group II indicates effective blockade of the chronotropic effects of NE. A higher propranolol dose was not given because in preliminary experiments Phenoxybenzamine produced effective alpha-receptor blockade in group I animals since the peripheral vascular resistance (PVR) did not increase during the 4-hour NE infusion. However, the increased PVR in group III (alpha and beta receptor + NE block) during the last 2 hours of NE infusion indicates incomplete alpha-receptor blockade. This effect may be due to an unmasking of alpha-receptor activity by beta-receptor blockade with propranolol (16) . This mechanism may also explain the fact that PVR was augmented to a greater degree in group II (beta-receptor block + NE) than in group VI when NE was infused alone.
The mechanisms by which NE, or more particularly, the action of NE that is mediated through the beta receptors, produces its characteristic morphologic effects on the heart remain speculative. The lesions are similar to the morphologic abnormalities associated with sympathetic nerve stimulation (17) and isoproterenol (18) . The subendocardial hemorrhage and the diffuse myofiber degeneration are two very distinctive lesions, and they may be mediated by entirely different mechanisms. Subendocardial hemorrhage is due to capillary or venular rupture probably from mechanical causes. Gauer has postulated that NE produces a sustained isometric contraction which persists following initial ejection (19) . If the heart volume is small, the subendocardial surfaces of the heart may contract against themselves, and the shearing and squeezing forces may produce a mechanical disruption of the delicate vascular channels. This postulation is supported by the observations in the present study. The subendocardial hemorrhage was most marked in the group I (alphareceptor block + NE) animals which had a low LVEDP and developed a significant systolic pressure difference between the left
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ventricle and the systemic circulation. Aortic outflow tract pressure differences have also been observed during the administration of the pure beta-receptor agent, isoproterenol (20) . This pressure difference, which was most marked in the second hour of NE infusion in the group I animals, suggests catheter entrapment in a small left ventricular cavity.
The myofiber degeneration during betareceptor stimulation with NE suggests a biochemical rather than a mechanical muscular mechanism. The NE lesions are associated with accumulation of small lipid droplets within the myofiber and with loss of respiratory enzyme activity. An hypoxic mechanism with either an oxygen supply deficit or "oxygen wasting" has been postulated in the pathogenesis of the catecholamine induced cardiac lesions (11, (21) (22) (23) . The recent metabolic studies of Regan during epinephrine and norepinephrine infusions do not support an ischemic theory (24, 25) . Furthermore, dissimilarities between catecholamine lesions (5, 9, 17, 18) and the morphologic (26) and biochemical (27) lesions of ischemic necrosis raise serious doubt about the traditionally postulated hypoxic mechanism. Enhanced triglyceride uptake by the myocardium during NE stimulation has been well documented (9, 25) and the lipid which accumulates within the myocellular elements may be a cause rather than a result of myofiber degeneration which ensues.
